BlackRock Fund Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $27.9M | Buy |
869,083
+77,667
| +10% | +$2.49M | 0.01% | 1993 |
|
|
2016
Q3 | $39.5M | Buy |
791,416
+75,118
| +10% | +$3.75M | 0.01% | 1732 |
|
|
2016
Q2 | $30.4M | Buy |
716,298
+44,772
| +7% | +$1.9M | 0.01% | 1796 |
|
|
2016
Q1 | $44.2M | Buy |
671,526
+2,764
| +0.4% | +$182K | 0.01% | 1529 |
|
|
2015
Q4 | $41.6M | Buy |
668,762
+5,073
| +0.8% | +$315K | 0.01% | 1598 |
|
|
2015
Q3 | $44.4M | Sell |
663,689
-1,794
| -0.3% | -$120K | 0.01% | 1493 |
|
|
2015
Q2 | $64.7M | Buy |
665,483
+32,389
| +5% | +$3.15M | 0.02% | 1348 |
|
|
2015
Q1 | $59.2M | Buy |
633,094
+29,920
| +5% | +$2.8M | 0.01% | 1408 |
|
|
2014
Q4 | $53.6M | Buy |
603,174
+51,389
| +9% | +$4.57M | 0.01% | 1418 |
|
|
2014
Q3 | $38.1M | Buy |
551,785
+17,492
| +3% | +$1.21M | 0.01% | 1540 |
|
|
2014
Q2 | $30.6M | Buy |
534,293
+69,236
| +15% | +$3.97M | 0.01% | 1742 |
|
|
2014
Q1 | $18.4M | Buy |
465,057
+14,580
| +3% | +$578K | 0.01% | 2044 |
|
|
2013
Q4 | $18.9M | Sell |
450,477
-8,085
| -2% | -$339K | 0.01% | 2019 |
|
|
2013
Q3 | $13.7M | Buy |
458,562
+84,104
| +22% | +$2.51M | ﹤0.01% | 2173 |
|
|
2013
Q2 | $19.9M | Buy |
+374,458
| New | +$19.9M | 0.01% | 1862 |
|